This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Sales from recently acquired Molecular Devices helped MDS Analytical Technologies post a 54 percent gain in second-quarter revenue year over year.
 
While MDS officials said they were pleased with Molecular Devices’ performance in the quarter, they reiterated their earlier revenue guidance of $190 million for the acquired business during MDS’ first full year of ownership.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.